14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.000001 $0.000001 Friday, 27th May 2022 ANTH stock ended at $0.000001. During the day the stock fluctuated 0% from a day low at $0.000001 to a day high of $0.000001.
90 days $0.000001 $0.000001
52 weeks $0.000001 $0.0850

Historical Anthera Pharmaceuticals prices

Date Open High Low Close Volume
Feb 09, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 08, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 07, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 04, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 03, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Feb 02, 2022 $0.000001 $0.000001 $0.000001 $0.000001 98
Feb 01, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 31, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 28, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 27, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 26, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 25, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 24, 2022 $0.000001 $0.000001 $0.000001 $0.000001 83 845
Jan 21, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 20, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 19, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 18, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 14, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 13, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 12, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 11, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 10, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 07, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 06, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Jan 05, 2022 $0.000001 $0.000001 $0.000001 $0.000001 0
Click to get the best stock tips daily for free!

About Anthera Pharmaceuticals

Anthera Pharmaceuticals Anthera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for patients with unmet medical needs. It develops Sollpura, a non-porcine investigational pancreatic enzyme replacement therapy that is in Phase III clinical trial for the treatment of patients with exocrine pancreatic insufficiency; and Blisibimod, which is in Phase II clinical trial for the treatment of B-cell mediated auto... ANTH Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT